Expert Review of Gastroenterology & Hepatology

ISSN: 1747-4124 (Print) 1747-4132 (Online) Journal homepage: http://www.tandfonline.com/loi/ierh20

Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease Valeria Dipasquale & Claudio Romano To cite this article: Valeria Dipasquale & Claudio Romano (2017): Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease, Expert Review of Gastroenterology & Hepatology, DOI: 10.1080/17474124.2018.1391091 To link to this article: http://dx.doi.org/10.1080/17474124.2018.1391091

Accepted author version posted online: 10 Oct 2017.

Submit your article to this journal

View related articles

View Crossmark data

Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=ierh20 Download by: [UNIVERSITY OF ADELAIDE LIBRARIES]

Date: 11 October 2017, At: 18:09

Publisher: Taylor & Francis Journal: Expert Review of Gastroenterology & Hepatology DOI: 10.1080/17474124.2018.1391091 Review

ip t

Pharmacological treatments and infectious diseases in pediatric inflammatory

cr

Valeria Dipasquale and Claudio Romano

us

Department of Human Pathology in Adulthood and Childhood, University of Messina,

an

Messina, Italy

M

Correspondence:

ed

Claudio Romano

University of Messina, Department of Human Pathology in Adulthood and Childhood “G.

ce pt

Barresi”, Via Consolare Valeria, 1, Messina, Italy 98125 E-mail: [email protected]

Ac

Downloaded by [UNIVERSITY OF ADELAIDE LIBRARIES] at 18:09 11 October 2017

bowel disease

1

Abstract Introduction: The incidence of pediatric inflammatory bowel disease (IBD) is rising, as is the employment of immunosuppressive and biological drugs. Most patients with IBD receive immunosuppressive therapies during the course of the disease. These molecules are a double-edged sword; while they can help control disease activity, they also increase

ip t

cr

pediatric gastroenterologists, and infectious disease physicians have a thorough

us

knowledge of the infections that can affect patients with IBD.

Areas covered: Abroad review of the major infectious diseases that have been reported

an

in children and adolescents with IBD was performed, and information regarding surveillance, diagnosis and management were updated. The possible correlations with IBD

M

pharmacological tools are discussed.

ed

Expert commentary: Opportunistic infections are possible in pediatric IBD, and immunosuppressive and immunomodulator therapy seems to play a causative role.

ce pt

Heightened awareness and vigilant surveillance leading to prompt diagnosis and treatment are important for optimal management. Keywords: biological therapy, child, infection, inflammatory bowel disease, immunomodulators

Ac

Downloaded by [UNIVERSITY OF ADELAIDE LIBRARIES] at 18:09 11 October 2017

the risk of infections. Therefore, it is important that pediatricians involved in primary care,

2

1. Introduction Inflammatory bowel diseases (IBDs) encompass Crohn’s disease (CD), ulcerative colitis (UC) and IBD-unclassified (IBD-U) according to the classification of Paris [1]. The Paris classification for CD includes classifying age at diagnosis as A1a (0 to

Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease.

The incidence of pediatric inflammatory bowel disease (IBD) is rising, as is the employment of immunosuppressive and biological drugs. Most patients w...
1004KB Sizes 0 Downloads 12 Views